Latest debt-to-equity ratio
AgomAb Therapeutics Debt-to-equity ratio
Direct answer
AgomAb Therapeutics's debt-to-equity ratio is 0.43%.
The verified market snapshot reports 0.43%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free AgomAb Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.43%